Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Editorial
Radioiodine: 80 years and counting; the past, present, and future
by Matthew D Ringel
Thematic Review
Radioiodine treatment: an historical and future perspective
by Patricia Borges de Souza and Christopher John McCabe
Tailoring the approach to radioactive iodine treatment in thyroid cancer
by Sarah E Mayson, Christine M Chan, and Bryan R Haugen
The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues
by Garcilaso Riesco-Eizaguirre, Pilar Santisteban, and Antonio De la Vieja
Na+/I− symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy
by Sissy M Jhiang and Jennifer A Sipos
Redifferentiation-facilitated radioiodine therapy in thyroid cancer
by Livia Lamartina et al.
The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment
by C Spitzweg et al.
Research
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents
by Li Qin et al.
Targeted genomic analysis of 364 adrenocortical carcinomas
by Nikita Pozdeyev et al.
Antitumor immune response is associated with favorable survival in GEP-NEN G3
by Vivian Rosery et al.
Access the issue online
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου